Analyst Reco. bioMérieux

Equities

Market Closed - Euronext Paris Other stock markets 11:35:03 2024-06-07 am EDT			5-day change	1st Jan Change
93.8 ^EUR	-0.90%		-3.45%	-6.76%

May. 29	BioMérieux: head injury test cleared by the FDA	CF
May. 28	BioMérieux: FDA clearance for Vidas TBI test	CF

BioMérieux: the rebound gains momentum, an analyst reinforces its case	May. 10	CF
BioMérieux: share price rises, analyst remains Buy	Apr. 26	CF
BIOMÉRIEUX : Berenberg raises its target	Apr. 26	CF
Deutsche Bank Initiates BioMérieux Coverage at Purchase	Apr. 23	MT
BIOMÉRIEUX : Deutsche Bank initiates buy coverage	Apr. 23	CF
Stifel Reaffirms bioMérieux at Buy, Lifts PT	Apr. 10	MT
BIOMÉRIEUX : Stifel raises target price	Apr. 10	CF
Invest Securities Lifts BioMérieux PT, Maintains at Buy	Apr. 10	MT
Oddo BHF Raises bioMérieux PT, Affirms Neutral Recommendation	Apr. 10	MT
BIOMÉRIEUX : Oddo BHF raises its target price	Apr. 10	CF
BIOMÉRIEUX : Invest Securities raises its target	Apr. 10	CF
BIOMERIEUX : A strong start to 2024	Apr. 09
Berenberg Upgrades BioMérieux to Buy from Hold, Lifts PT	Mar. 21	MT
BIOMÉRIEUX : Berenberg upgrades its recommendation to 'buy	Mar. 21	CF
BioMérieux: Invest Securities reiterates its opinion	Mar. 15	CF
Invest Securities Keeps BioMérieux at Buy, Reduces PT	Mar. 15	MT
BIOMÉRIEUX : Invest Securities remains positive, reduces its target	Mar. 15	CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact	Mar. 14
Invest Securities Lowers BioMérieux's PT, Keeps Buy Rating	23-10-27	MT
BIOMERIEUX : Healthy performances across the non-COVID-19 offerings; guidance maintained	23-10-27

No results for this search

BIOMERIEUX : A strong start to 2024

April 09, 2024 at 10:38 am EDT